Sitagliptin Accelerates Endothelial Regeneration after Vascular Injury Independent from GLP1 Receptor Signaling.

about

Is there a Chance to Promote Arteriogenesis by DPP4 Inhibitors Even in Type 2 Diabetes? A Critical Review

P2860

Q58579298-4DA07B30-309F-42FA-84E5-77C8368E1554

P2860

Sitagliptin Accelerates Endothelial Regeneration after Vascular Injury Independent from GLP1 Receptor Signaling.

Item

http://www.wikidata.org/entity/Q52807797

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Sitagliptin Accelerates Endoth ...... from GLP1 Receptor Signaling.

@en

Sitagliptin Accelerates Endoth ...... from GLP1 Receptor Signaling.

@nl

type

Item

label

Sitagliptin Accelerates Endoth ...... from GLP1 Receptor Signaling.

@en

Sitagliptin Accelerates Endoth ...... from GLP1 Receptor Signaling.

@nl

prefLabel

Sitagliptin Accelerates Endoth ...... from GLP1 Receptor Signaling.

@en

Sitagliptin Accelerates Endoth ...... from GLP1 Receptor Signaling.

@nl

P1476

Sitagliptin Accelerates Endoth ...... from GLP1 Receptor Signaling.

@en

P2093

Daniela Lener

http://www.w3.org/2001/XMLSchema#string

Nicolle Kränkel

http://www.w3.org/2001/XMLSchema#string

P2860

Gliptins and their target dipeptidyl peptidase 4: implications for the treatment of vascular disease

Platelet-derived CXCL12 regulates monocyte function, survival, differentiation into macrophages and foam cells through differential involvement of CXCR4-CXCR7

Stromal cell-derived factor-1alpha induces astrocyte proliferation through the activation of extracellular signal-regulated kinases 1/2 pathway

ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collab

Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes.

Preventive effect of dipeptidyl peptidase-4 inhibitor on atherosclerosis is mainly attributable to incretin's actions in nondiabetic and diabetic apolipoprotein E-null mice

Effects of exenatide on postprandial vascular endothelial dysfunction in type 2 diabetes mellitus

Stromal cell-derived factor-1 (SDF1)-dependent recruitment of bone marrow-derived renal endothelium-like cells in a mouse model of acute kidney injury

Pancreatic GLP-1 receptor activation is sufficient for incretin control of glucose metabolism in mice.

The Effect of Sitagliptin on Carotid Artery Atherosclerosis in Type 2 Diabetes: The PROLOGUE Randomized Controlled Trial.

P304

5284963

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2018/5284963

http://www.w3.org/2001/XMLSchema#string

P478

2018

http://www.w3.org/2001/XMLSchema#string

P50

P577

2018-02-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29531541

http://www.w3.org/2001/XMLSchema#string

P932

5822806

http://www.w3.org/2001/XMLSchema#string

Sitagliptin Accelerates Endothelial Regeneration after Vascular Injury Independent from GLP1 Receptor Signaling.

about

P2860

P2860

Sitagliptin Accelerates Endothelial Regeneration after Vascular Injury Independent from GLP1 Receptor Signaling.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P698

P932